Zafirlukast, a leukotriene receptor antagonist, stands as a crucial player in the management of asthma, a chronic respiratory condition characterized by airway inflammation and bronchospasm.
Singulair, also known by its active ingredient montelukast, stands as a prominent medication in the realm of asthma management. Its unique mechanism of action targets